ada standards of care 2025 obesity pharmacotherapy glp-1 recommendations guidelines for diabetes glycemic management ADA Releases New Obesity Treatment

The compounds research profile now spans adipose tissue biology, skeletal muscle physiology, gut microbiome modulation, cardiovascular metabolic pathways, and cancer cell biology

GLP-1/GIP combination therapy adds a second hormone pathway into the mix, which may offer additional metabolic support for certain patients

What is Fridays doing right

The mechanism VEGF-A upregulation (ELISA, RT-qPCR), VEGFR2 phosphorylation (pY1175 western blot), and eNOS Akt-Ser1177 phosphorylation (NO bioavailability for vasodilation and tube formation) is well-characterised

For example, one JAMA analysis found that among initially-rejected branded prescriptions (all drugs), only 54% were ultimately approved after appeals and resubmissions ( [5] )

AhnW-SKimD-JChaeG-TLeeJ-MBaeS-MSinJ-Iet al